Works matching IS 14783223 AND DT 2020 AND VI 40 AND IP 5
Results: 35
ERRATUM.
- Published in:
- 2020
- Publication type:
- Correction Notice
Fatal emphysematous hepatitis with spontaneous pneumoperitoneum.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1224, doi. 10.1111/liv.14450
- By:
- Publication type:
- Article
ERRATUM.
- Published in:
- 2020
- Publication type:
- Correction Notice
ERRATUM.
- Published in:
- 2020
- Publication type:
- Correction Notice
Issue Cover.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. i, doi. 10.1111/liv.14443
- By:
- Publication type:
- Article
Liver injury during highly pathogenic human coronavirus infections.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 998, doi. 10.1111/liv.14435
- By:
- Publication type:
- Article
Redefining fatty liver disease classification in 2020.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1016, doi. 10.1111/liv.14430
- By:
- Publication type:
- Article
Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1121, doi. 10.1111/liv.14429
- By:
- Publication type:
- Article
Hepatoprotective impact of the bile acid receptor TGR5.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1005, doi. 10.1111/liv.14427
- By:
- Publication type:
- Article
Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1225, doi. 10.1111/liv.14425
- By:
- Publication type:
- Article
Low‐GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1142, doi. 10.1111/liv.14422
- By:
- Publication type:
- Article
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1130, doi. 10.1111/liv.14419
- By:
- Publication type:
- Article
Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1111, doi. 10.1111/liv.14417
- By:
- Publication type:
- Article
Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1052, doi. 10.1111/liv.14415
- By:
- Publication type:
- Article
The amount of liver fat predicts mortality and development of type 2 diabetes in non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1069, doi. 10.1111/liv.14414
- By:
- Publication type:
- Article
HSP4 triggers epithelial‐mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1211, doi. 10.1111/liv.14410
- By:
- Publication type:
- Article
The association between etiology of hepatocellular carcinoma and race‐ethnicity in Florida.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1201, doi. 10.1111/liv.14409
- By:
- Publication type:
- Article
Evaluation of a serum tumour marker‐based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1189, doi. 10.1111/liv.14406
- By:
- Publication type:
- Article
ITTREAT (I ntegrated Community T est ‐ Stage ‐ TREAT) Hepatitis C service for people who use drugs: Real‐world outcomes.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1021, doi. 10.1111/liv.14403
- By:
- Publication type:
- Article
Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1098, doi. 10.1111/liv.14402
- By:
- Publication type:
- Article
Renal function in HCV therapy: Just another thing to ignore?
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1018, doi. 10.1111/liv.14391
- By:
- Publication type:
- Article
Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1089, doi. 10.1111/liv.14385
- By:
- Publication type:
- Article
The endothelial function biomarker soluble E‐selectin is associated with nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1079, doi. 10.1111/liv.14384
- By:
- Publication type:
- Article
Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1178, doi. 10.1111/liv.14358
- By:
- Publication type:
- Article
Congenital antithrombin deficiency in patients with splanchnic vein thrombosis.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1168, doi. 10.1111/liv.14342
- By:
- Publication type:
- Article
High rate of sustained virological response with direct‐acting antivirals in haemophiliacs with HCV infection: A multicenter study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1062, doi. 10.1111/liv.14337
- By:
- Publication type:
- Article
Response to: Prognostication of HCC patients under sorafenib is not always possible.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1243, doi. 10.1111/liv.14335
- By:
- Publication type:
- Article
Risk prediction scores for acute on chronic liver failure development and mortality.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1159, doi. 10.1111/liv.14328
- By:
- Publication type:
- Article
Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1151, doi. 10.1111/liv.14325
- By:
- Publication type:
- Article
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1032, doi. 10.1111/liv.14320
- By:
- Publication type:
- Article
Author response: Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1240, doi. 10.1111/liv.14318
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1042, doi. 10.1111/liv.14313
- By:
- Publication type:
- Article
Prognostication of HCC under sorafenib: Is it always possible?
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1241, doi. 10.1111/liv.14294
- By:
- Publication type:
- Article
Cognitive impairment in patients with nonalcoholic fatty liver disease with liver fibrosis.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1239, doi. 10.1111/liv.14288
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 993, doi. 10.1111/liv.14144
- Publication type:
- Article